Knockout of antigen-presenting genes, including MHC-I and B2M, enhances the sensitivity of across hematologic cancer cell lines to NK cells, supporting the “missing-self” mechanism of NK cell activation. The gene discussed is B2M; the disease is hematopoietic and lymphoid cell neoplasm.